123
Views
11
CrossRef citations to date
0
Altmetric
Nephrology

Tamm–Horsfall protein gene is associated with distal tubular dysfunction in patients with type 1 diabetes

&
Pages 438-444 | Received 02 Dec 2009, Accepted 18 Jun 2010, Published online: 13 Jul 2010

References

  • Rasch R, Torffvit O, Bachman S, Jensen PK, Jacobsen NO. Tamm–Horsfall glycoprotein in streptozotocin diabetic rats: A study of kidney in situ hybridization, immunohistochemistry and urinary excretion. Diabetologia 1995;38:525–35.
  • Torffvit O, Jørgensen PE, Kamper A-L, Hostein-Rathlou NH, Leyssac PP, Poulsen SS, Strandgaard S. Urinary excretion of Tamm–Horsfall protein and epidermal growth factor in chronic nephropathy. Nephron 1998;79:167–72.
  • Torffvit O, Agardh C-D. Urinary excretion rate of NC1 and Tamm–Horsfall protein in the microalbuminuric type I diabetic patient. J Diabet Complications 1994;8:77–83.
  • Ginevri F, Piccotti E, Alinovi R, DeToni T, Biagini C, Chifferi GM, Gusmano R. Reversible tubular proteinuria precedes microalbuminuria and correlates with the metabolic status in diabetic children. Pediatr Nephrol 1993;7:23–6.
  • Pfleiderer S, Zimmerhackl L, Kinne R, Manz F, Schuler G, Brandis M. Renal proximal and distal tubular function is attenuated in diabetes mellitus type 1 as determined by the renal excretion of α1-microglobulin and Tamm–Horsfall protein. Clin Invest 1993;71:972–7.
  • Schultz C, Dalton R, Neil H, Konopelska-Bahu T, Dunger D, on behalf of the Oxford Regional Prospective Study Group. Markers of renal tubular dysfunction measured annually do not predict risk of microalbuminuria in the first few years after diagnosis of type 1 diabetes. Diabetologia 2001;44:224–9.
  • Torffvit O, Melander O, Hultén UL. Urinary excretion rate of Tamm–Horsfall protein is related to salt intake in humans. Nephron Physiol 2004;97:31–6.
  • Thorup C, Ollerstam A, Persson AEG, Torffvit O. Increased tubuloglomerular feedback activity is associated with increased NO production in the streptozotocin-diabetic rat. J Diabetes Complications 2000;14:46–52.
  • Mogensen C, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984;311:89–93.
  • Rudberg S, Persson B, Dahlquist G. Increased glomerular filtration rate is a predictor of diabetic nephropathy – an 8-year prospective study. Kidney Int 1992;41:822–8.
  • Sejdiu I, Torffvit O. Decreased urinary concentration of Tamm–Horsfall protein is associated with development of renal failure and cardiovascular death within 20 years in type 1 but not in type 2 diabetic patients. Scand J Urol Nephrol 2008;42:168–74.
  • Holmquist P, Torffvit O, Jorgensen P, Torring N, Nexo E, Sjöblad S. Early urinary changes in Tamm–Horsfall protein and epidermal growth factor in diabetic children. Pediatr Nephrol 2001;16:488–92.
  • Torffvit O, Edvinsson L. Blockade of nitric oxide decreases the renal vasodilatory effect of neuropeptide Y in the insulin-treated diabetic rat. Eur J Physiol 1997;434:445–50.
  • Torffvit O, Edvinsson L. Relaxing effect of insulin in renal arteries from diabetic rats. Regul Pept 1999;79:147–52.
  • Zanchi A, Moczulski D, Hanna L, Wantman M, Warram J, Krolewski AS. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int 2000;57:405–13.
  • Möllsten A, Lajer M, Jorsal A, Tarnow L. The endothelial nitric oxide synthase gene and risk of diabetic nephropathy and development of cardiovascular disease in type 1 diabetes. Mol Genet Metab 2009;97:80–4.
  • Möllsten A, Wessman M, Svensson M, Forsblom C, Parkkonen M, Brismar K, Glu298Asp and NOS4ab polymorphisms in diabetic nephropathy. Ann Med 2006;38:522–8.
  • Wang X, Sim A, Badenhop R, McCredie R, Wilcken DE. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 1996;ii:41–5.
  • Torffvit O, Agardh C-D, Kjellsson B, Wieslander J. Tubular secretion of Tamm–Horsfall protein in type 1 (insulin-dependent) diabetes mellitus using a simplified enzyme linked immunoassay. Clin Chim Acta 1992;205:31–41.
  • Raile K, Galler A, Hofer S, Herbst A, Dunstheimer D, Busch P, Holl RW. Diabetic nephropathy in 27805 children, adolescents, and adults with type 1 diabetes. Effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex. Diabetes Care 2007;30:2523–8.
  • Torffvit O, Agardh C-D. The impact of metabolic and blood pressure control on incidence and progression of nephropathy. A 10-year study of 385 type 2 diabetic patients. J Diabet Complications 2001;15:307–13.
  • Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS. Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 1999;19:1992–7.
  • Viberti G, Jarrett R, Mahmud U, Hill R, Argyropoulos A, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982;319:1430–2.
  • Torffvit O, Rippe B. Size and charge selectivity of the glomerular filter in patients with insulin-dependent diabetes mellitus: urinary immunoglobulins and glycosaminoglycans. Nephron 1999;83:301–7.
  • Bangstad H-J, Kofoed-Enevoldsen A, Dahl-Jørgensen K, Hanssen KF. Glomerular charge selectivity and the influence of improved blood glucose control in Type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 1992;35:1165–9.
  • Thulesen J, Jørgensen P, Torffvit O, Nexø E, Poulsen SS. Urinary excretion of epidermal growth factor and Tamm–Horsfall protein in three rat models with increased renal excretion of urine. Regul Pept 1997;72:179–86.
  • Lövestam-Adrian M, Hansson-Lundblad C, Torffvit O. Sight-threatening retinopathy is associated with lower mortality in type 2 diabetic subjects: a 10-year observation study. Diabetes Res Clin Pract 2007;77:141–7.
  • Catalano C, Torffvit O. Urinary excretion of Tamm–Horsfall protein in normotensive, normo-albuminuric type 1 diabetic patients. Nephron 1996;72:436–41.
  • Wang X, Mahaney M, Sim A, Wang J, Wang J, Blangero J, Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol 1997;17:3147–53.
  • Tsukada T, Yokoyama K, Arai T, Takemoto F, Hara S, Yamada A, Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun 1998;245:190–3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.